NCT01021787已完成4 期
Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF 40 Sunscreen Cream With Micronized TiO2 and Anthelios SX SPF 40 Cream (With Pigmentary TiO2) Into the Stratum Corneum of Compromised (Induced Sunburn) Human Skin
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- Loreal USA
- 入组人数
- 26
- 试验地点
- 2
- 主要终点
- Determine degree of penetration of TiO2 down to 16 -20 tape strips of human skin
研究概览
简要总结
To determine the penetration of micronized and pigmentary TiO2 in Formulas 283419 2 and 760.001 into the stratum corneum of Compromised (Induced Sunburn) human skin via skin stripping of human subjects.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •All subjects must:
- •be between the ages of 18 and
- •agree to not participate in any other product evaluations or clinical evaluations during the course of this study.
- •have read, understood and signed an Informed Consent Form.
- •have intact skin in the treatment area.
- •have fair skin - Skin Types I, or II - as defined in Appendix II.
- •be able to understand and willing to follow all study procedures and restrictions.
排除标准
- •Subjects will be excluded from participating in the study if they:
- •are female and are pregnant or lactating [must be using an acceptable method of birth control if of child bearing potential].*
- •exhibit any visible symptoms of skin disease, such as psoriasis or eczema, or skin abnormality (including active dermal lesions, uneven skin tone or scars) which might interfere with interpretation of the study results. The presence of nevi, blemishes, or moles will be acceptable if, in the Investigator's judgement, they will not interfere with the study results or skin stripping procedures.
- •have a history of allergic responses to sunscreens or other products similar to those included in this study.
- •have very dry or scaly skin on the test site.
- •have diabetes.
- •have a history of abnormal responses to sunlight, such as a phototoxic or photoallergic response.
- •have an existing sunburn or suntan, or been to a tanning booth which would interfere with interpretation of the study results.
- •have used self tanners within the past two weeks.
- •have excessive hair at the test site area which could, in the opinion of the investigator, interfere with the interpretation of the results.
- •have participated in a research drug trial or patch test within six weeks of beginning this study.
- •have a known sensitivity to Scotch 600 Transparent Tape.
- •are currently receiving, or within the past two weeks received, topical or systemic medication which could, in the opinion of the investigator, interfere with the interpretation of the results, affect the safety of the subject, or which may change the body's response to ultraviolet light.
- •are currently taking any of the drugs listed on the next page. In addition, the use of St. John's Wort or other similar dietary supplements, aspirin or OTC ibuprofen is contraindicated for the duration of the study. Low dose daily aspirin use, 81 mgs, taken for heart attack prevention is excluded.
- •Acceptable methods of birth control that can be used during the course of the study are: oral contraceptive pill, intrauterine device, patch, injection, condom with spermicide, partner vasectomy, bilateral tubal ligation, abstinence or evidence of non childbearing potential (i.e., post-menopausal [one year without menstrual period], hysterectomy or bilateral ovariectomy).
结局指标
主要结局
Determine degree of penetration of TiO2 down to 16 -20 tape strips of human skin
时间窗: Single application
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Microdialysis and Pharmacokinetic Study of TR-701HealthyNCT00666601Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)15
已完成
1 期
Tedizolid Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo MicrodialysisHealthy VolunteersDiabetesWound InfectionNCT02620787Hartford Hospital18
已完成
不适用
Transcutaneous Application of Gaseous CO2NCT04561609University Medical Centre Ljubljana120
已完成
2 期
Efficacy and Safety of TF002 in Cutaneous MastocytosisCutaneous MastocytosisNCT00457288JADO Technologies GmbH30
终止
2 期
Phase 2a Study Evaluating the Arsenic Trioxide (ATO) in Systemic Lupus (SLE) (Protocol LUPSENIC)Systemic LupusNCT01738360Nantes University Hospital11